Other Modified FDA Import Alerts for the Week of Feb. 16-22
During the week of Feb. 16-22, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination and/or surveillance of:
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
- 99-22: Foods Containing Undeclared Major Food Allergens Or Foods That Fail To Properly Label Major Food Allergens (here)
- 66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122 (here)
- 66-49: All Polidocanol Finished Dosage Form Products And Active Pharmaceutical Ingredients (APIs) From All Sources Under All Brand Names Including Aetoxisclerol, Aethoxysklerol, And Sclerovein (here)
- 66-05: Foreign Labeled Finished Dosage Parenterals (here)
- 53-19: Henna Based Skin Color (here)
- 23-12: Coconut Due to the Presence of Microbiological Contamination (here)